methylene blue has been researched along with Familial Nonmedullary Thyroid Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Guo, G; Hu, X; Huang, D; Huang, O; Jin, C; Li, Q; Pan, Y; Qu, J; Wang, O; Wu, W; Xiang, Y; Yang, K; You, J; Zhang, X; Zhou, S | 1 |
1 trial(s) available for methylene blue and Familial Nonmedullary Thyroid Cancer
| Article | Year |
|---|---|
Sentinel lymph node biopsy is unsuitable for routine practice in younger female patients with unilateral low-risk papillary thyroid carcinoma.
Topics: Adult; Carcinoma; Carcinoma, Papillary; False Negative Reactions; False Positive Reactions; Female; Humans; Lymph Nodes; Methylene Blue; Neck Dissection; Neoplasm Metastasis; Prospective Studies; Radionuclide Imaging; Sentinel Lymph Node Biopsy; Surgery, Computer-Assisted; Technetium; Thyroid Cancer, Papillary; Thyroid Neoplasms; Young Adult | 2011 |